0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Animal Antibacterial Peptide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-20G6893
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Animal Antibacterial Peptide Market Insights and Forecast to 2028
BUY CHAPTERS

Animal Antibacterial Peptide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-20G6893
Report
September 2024
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Animal Antibacterial Peptide - Market Size

According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021.

Animal Antibacterial Peptide - Market

Animal Antibacterial Peptide - Market

Peptides are derived from animal source and possess antibacterial activity that comes under animal antibacterial peptides. They contain residue of amino acids generally about 15 to 45. Antibacterial peptides are the effector molecules of innate immunity. Majority of the antibacterial peptides are cationic in nature. In insects, the cecropin type of linear peptide without cysteine are found. Now, more than 900 sequences of proteins and antibacterial peptides from plants and animals are stored in database. The antibacterial peptides are broad spectrum in activity. The antibacterial peptides are amphipathic in structure and contains positive charge.
The global market for Animal Antibacterial Peptide was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 177%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Animal Antibacterial Peptide, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Animal Antibacterial Peptide by region & country, by Type, and by Application.
The Animal Antibacterial Peptide market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Antibacterial Peptide.
Market Segmentation

Scope of Animal Antibacterial Peptide - Market Report

Report Metric Details
Report Name Animal Antibacterial Peptide - Market
Accounted market size in 2021 $ 38.3 billion
Base Year 2021
Segment by Type:
  • Anionic Peptides
  • Cationic Peptide
Segment by Application
  • Poultry
  • Livestock
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merial, Zoetis, Bayer HealthCare, Merck Animal Health, Elanco (Eli Lilly and Company), Biogenesis Bago, Animal Medics, Boehringer Ingelheim Vetmedica
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Animal Antibacterial Peptide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Animal Antibacterial Peptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Animal Antibacterial Peptide in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Animal Antibacterial Peptide - Market share by region?

Ans: In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Animal Antibacterial Peptide - Market report?

Ans: The main players in the Animal Antibacterial Peptide - Market are Merial, Zoetis, Bayer HealthCare, Merck Animal Health, Elanco (Eli Lilly and Company), Biogenesis Bago, Animal Medics, Boehringer Ingelheim Vetmedica

What are the Application segmentation covered in the Animal Antibacterial Peptide - Market report?

Ans: The Applications covered in the Animal Antibacterial Peptide - Market report are Poultry, Livestock

What are the Type segmentation covered in the Animal Antibacterial Peptide - Market report?

Ans: The Types covered in the Animal Antibacterial Peptide - Market report are Anionic Peptides, Cationic Peptide

1 Market Overview
1.1 Animal Antibacterial Peptide Product Introduction
1.2 Global Animal Antibacterial Peptide Market Size Forecast
1.2.1 Global Animal Antibacterial Peptide Sales Value (2019-2030)
1.2.2 Global Animal Antibacterial Peptide Sales Volume (2019-2030)
1.2.3 Global Animal Antibacterial Peptide Sales Price (2019-2030)
1.3 Animal Antibacterial Peptide Market Trends & Drivers
1.3.1 Animal Antibacterial Peptide Industry Trends
1.3.2 Animal Antibacterial Peptide Market Drivers & Opportunity
1.3.3 Animal Antibacterial Peptide Market Challenges
1.3.4 Animal Antibacterial Peptide Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Animal Antibacterial Peptide Players Revenue Ranking (2023)
2.2 Global Animal Antibacterial Peptide Revenue by Company (2019-2024)
2.3 Global Animal Antibacterial Peptide Players Sales Volume Ranking (2023)
2.4 Global Animal Antibacterial Peptide Sales Volume by Company Players (2019-2024)
2.5 Global Animal Antibacterial Peptide Average Price by Company (2019-2024)
2.6 Key Manufacturers Animal Antibacterial Peptide Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Animal Antibacterial Peptide Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Animal Antibacterial Peptide
2.9 Animal Antibacterial Peptide Market Competitive Analysis
2.9.1 Animal Antibacterial Peptide Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Animal Antibacterial Peptide Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Antibacterial Peptide as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Anionic Peptides
3.1.2 Cationic Peptide
3.2 Global Animal Antibacterial Peptide Sales Value by Type
3.2.1 Global Animal Antibacterial Peptide Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Animal Antibacterial Peptide Sales Value, by Type (2019-2030)
3.2.3 Global Animal Antibacterial Peptide Sales Value, by Type (%) (2019-2030)
3.3 Global Animal Antibacterial Peptide Sales Volume by Type
3.3.1 Global Animal Antibacterial Peptide Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Animal Antibacterial Peptide Sales Volume, by Type (2019-2030)
3.3.3 Global Animal Antibacterial Peptide Sales Volume, by Type (%) (2019-2030)
3.4 Global Animal Antibacterial Peptide Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Poultry
4.1.2 Livestock
4.2 Global Animal Antibacterial Peptide Sales Value by Application
4.2.1 Global Animal Antibacterial Peptide Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Animal Antibacterial Peptide Sales Value, by Application (2019-2030)
4.2.3 Global Animal Antibacterial Peptide Sales Value, by Application (%) (2019-2030)
4.3 Global Animal Antibacterial Peptide Sales Volume by Application
4.3.1 Global Animal Antibacterial Peptide Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Animal Antibacterial Peptide Sales Volume, by Application (2019-2030)
4.3.3 Global Animal Antibacterial Peptide Sales Volume, by Application (%) (2019-2030)
4.4 Global Animal Antibacterial Peptide Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Animal Antibacterial Peptide Sales Value by Region
5.1.1 Global Animal Antibacterial Peptide Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Animal Antibacterial Peptide Sales Value by Region (2019-2024)
5.1.3 Global Animal Antibacterial Peptide Sales Value by Region (2025-2030)
5.1.4 Global Animal Antibacterial Peptide Sales Value by Region (%), (2019-2030)
5.2 Global Animal Antibacterial Peptide Sales Volume by Region
5.2.1 Global Animal Antibacterial Peptide Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Animal Antibacterial Peptide Sales Volume by Region (2019-2024)
5.2.3 Global Animal Antibacterial Peptide Sales Volume by Region (2025-2030)
5.2.4 Global Animal Antibacterial Peptide Sales Volume by Region (%), (2019-2030)
5.3 Global Animal Antibacterial Peptide Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Animal Antibacterial Peptide Sales Value, 2019-2030
5.4.2 North America Animal Antibacterial Peptide Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Animal Antibacterial Peptide Sales Value, 2019-2030
5.5.2 Europe Animal Antibacterial Peptide Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Animal Antibacterial Peptide Sales Value, 2019-2030
5.6.2 Asia Pacific Animal Antibacterial Peptide Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Animal Antibacterial Peptide Sales Value, 2019-2030
5.7.2 South America Animal Antibacterial Peptide Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Animal Antibacterial Peptide Sales Value, 2019-2030
5.8.2 Middle East & Africa Animal Antibacterial Peptide Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Animal Antibacterial Peptide Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Animal Antibacterial Peptide Sales Value
6.2.1 Key Countries/Regions Animal Antibacterial Peptide Sales Value, 2019-2030
6.2.2 Key Countries/Regions Animal Antibacterial Peptide Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Animal Antibacterial Peptide Sales Value, 2019-2030
6.3.2 United States Animal Antibacterial Peptide Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Animal Antibacterial Peptide Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Animal Antibacterial Peptide Sales Value, 2019-2030
6.4.2 Europe Animal Antibacterial Peptide Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Animal Antibacterial Peptide Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Animal Antibacterial Peptide Sales Value, 2019-2030
6.5.2 China Animal Antibacterial Peptide Sales Value by Type (%), 2023 VS 2030
6.5.3 China Animal Antibacterial Peptide Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Animal Antibacterial Peptide Sales Value, 2019-2030
6.6.2 Japan Animal Antibacterial Peptide Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Animal Antibacterial Peptide Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Animal Antibacterial Peptide Sales Value, 2019-2030
6.7.2 South Korea Animal Antibacterial Peptide Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Animal Antibacterial Peptide Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Animal Antibacterial Peptide Sales Value, 2019-2030
6.8.2 Southeast Asia Animal Antibacterial Peptide Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Animal Antibacterial Peptide Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Animal Antibacterial Peptide Sales Value, 2019-2030
6.9.2 India Animal Antibacterial Peptide Sales Value by Type (%), 2023 VS 2030
6.9.3 India Animal Antibacterial Peptide Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merial
7.1.1 Merial Company Information
7.1.2 Merial Introduction and Business Overview
7.1.3 Merial Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merial Animal Antibacterial Peptide Product Offerings
7.1.5 Merial Recent Development
7.2 Zoetis
7.2.1 Zoetis Company Information
7.2.2 Zoetis Introduction and Business Overview
7.2.3 Zoetis Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Zoetis Animal Antibacterial Peptide Product Offerings
7.2.5 Zoetis Recent Development
7.3 Bayer HealthCare
7.3.1 Bayer HealthCare Company Information
7.3.2 Bayer HealthCare Introduction and Business Overview
7.3.3 Bayer HealthCare Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Bayer HealthCare Animal Antibacterial Peptide Product Offerings
7.3.5 Bayer HealthCare Recent Development
7.4 Merck Animal Health
7.4.1 Merck Animal Health Company Information
7.4.2 Merck Animal Health Introduction and Business Overview
7.4.3 Merck Animal Health Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Merck Animal Health Animal Antibacterial Peptide Product Offerings
7.4.5 Merck Animal Health Recent Development
7.5 Elanco (Eli Lilly and Company)
7.5.1 Elanco (Eli Lilly and Company) Company Information
7.5.2 Elanco (Eli Lilly and Company) Introduction and Business Overview
7.5.3 Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Product Offerings
7.5.5 Elanco (Eli Lilly and Company) Recent Development
7.6 Biogenesis Bago
7.6.1 Biogenesis Bago Company Information
7.6.2 Biogenesis Bago Introduction and Business Overview
7.6.3 Biogenesis Bago Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Biogenesis Bago Animal Antibacterial Peptide Product Offerings
7.6.5 Biogenesis Bago Recent Development
7.7 Animal Medics
7.7.1 Animal Medics Company Information
7.7.2 Animal Medics Introduction and Business Overview
7.7.3 Animal Medics Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Animal Medics Animal Antibacterial Peptide Product Offerings
7.7.5 Animal Medics Recent Development
7.8 Boehringer Ingelheim Vetmedica
7.8.1 Boehringer Ingelheim Vetmedica Company Information
7.8.2 Boehringer Ingelheim Vetmedica Introduction and Business Overview
7.8.3 Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Product Offerings
7.8.5 Boehringer Ingelheim Vetmedica Recent Development
8 Industry Chain Analysis
8.1 Animal Antibacterial Peptide Industrial Chain
8.2 Animal Antibacterial Peptide Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Animal Antibacterial Peptide Sales Model
8.5.2 Sales Channel
8.5.3 Animal Antibacterial Peptide Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Animal Antibacterial Peptide Market Trends
    Table 2. Animal Antibacterial Peptide Market Drivers & Opportunity
    Table 3. Animal Antibacterial Peptide Market Challenges
    Table 4. Animal Antibacterial Peptide Market Restraints
    Table 5. Global Animal Antibacterial Peptide Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Animal Antibacterial Peptide Revenue Market Share by Company (2019-2024)
    Table 7. Global Animal Antibacterial Peptide Sales Volume by Company (2019-2024) & (K MT)
    Table 8. Global Animal Antibacterial Peptide Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Animal Antibacterial Peptide Price by Company (2019-2024) & (USD/MT)
    Table 10. Key Manufacturers Animal Antibacterial Peptide Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Animal Antibacterial Peptide Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Animal Antibacterial Peptide
    Table 13. Global Animal Antibacterial Peptide Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Antibacterial Peptide as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Animal Antibacterial Peptide Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Animal Antibacterial Peptide Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Animal Antibacterial Peptide Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Animal Antibacterial Peptide Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Animal Antibacterial Peptide Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Animal Antibacterial Peptide Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
    Table 22. Global Animal Antibacterial Peptide Sales Volume by Type (2019-2024) & (K MT)
    Table 23. Global Animal Antibacterial Peptide Sales Volume by Type (2025-2030) & (K MT)
    Table 24. Global Animal Antibacterial Peptide Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Animal Antibacterial Peptide Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Animal Antibacterial Peptide Price by Type (2019-2024) & (USD/MT)
    Table 27. Global Animal Antibacterial Peptide Price by Type (2025-2030) & (USD/MT)
    Table 28. Global Animal Antibacterial Peptide Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Animal Antibacterial Peptide Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Animal Antibacterial Peptide Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Animal Antibacterial Peptide Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Animal Antibacterial Peptide Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Animal Antibacterial Peptide Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
    Table 34. Global Animal Antibacterial Peptide Sales Volume by Application (2019-2024) & (K MT)
    Table 35. Global Animal Antibacterial Peptide Sales Volume by Application (2025-2030) & (K MT)
    Table 36. Global Animal Antibacterial Peptide Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Animal Antibacterial Peptide Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Animal Antibacterial Peptide Price by Application (2019-2024) & (USD/MT)
    Table 39. Global Animal Antibacterial Peptide Price by Application (2025-2030) & (USD/MT)
    Table 40. Global Animal Antibacterial Peptide Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Animal Antibacterial Peptide Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Animal Antibacterial Peptide Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Animal Antibacterial Peptide Sales Value by Region (2019-2024) & (%)
    Table 44. Global Animal Antibacterial Peptide Sales Value by Region (2025-2030) & (%)
    Table 45. Global Animal Antibacterial Peptide Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
    Table 46. Global Animal Antibacterial Peptide Sales Volume by Region (2019-2024) & (K MT)
    Table 47. Global Animal Antibacterial Peptide Sales Volume by Region (2025-2030) & (K MT)
    Table 48. Global Animal Antibacterial Peptide Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Animal Antibacterial Peptide Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Animal Antibacterial Peptide Average Price by Region (2019-2024) & (USD/MT)
    Table 51. Global Animal Antibacterial Peptide Average Price by Region (2025-2030) & (USD/MT)
    Table 52. Key Countries/Regions Animal Antibacterial Peptide Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Animal Antibacterial Peptide Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Animal Antibacterial Peptide Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Animal Antibacterial Peptide Sales Volume, (2019-2024) & (K MT)
    Table 56. Key Countries/Regions Animal Antibacterial Peptide Sales Volume, (2025-2030) & (K MT)
    Table 57. Merial Company Information
    Table 58. Merial Introduction and Business Overview
    Table 59. Merial Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 60. Merial Animal Antibacterial Peptide Product Offerings
    Table 61. Merial Recent Development
    Table 62. Zoetis Company Information
    Table 63. Zoetis Introduction and Business Overview
    Table 64. Zoetis Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 65. Zoetis Animal Antibacterial Peptide Product Offerings
    Table 66. Zoetis Recent Development
    Table 67. Bayer HealthCare Company Information
    Table 68. Bayer HealthCare Introduction and Business Overview
    Table 69. Bayer HealthCare Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 70. Bayer HealthCare Animal Antibacterial Peptide Product Offerings
    Table 71. Bayer HealthCare Recent Development
    Table 72. Merck Animal Health Company Information
    Table 73. Merck Animal Health Introduction and Business Overview
    Table 74. Merck Animal Health Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 75. Merck Animal Health Animal Antibacterial Peptide Product Offerings
    Table 76. Merck Animal Health Recent Development
    Table 77. Elanco (Eli Lilly and Company) Company Information
    Table 78. Elanco (Eli Lilly and Company) Introduction and Business Overview
    Table 79. Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 80. Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Product Offerings
    Table 81. Elanco (Eli Lilly and Company) Recent Development
    Table 82. Biogenesis Bago Company Information
    Table 83. Biogenesis Bago Introduction and Business Overview
    Table 84. Biogenesis Bago Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 85. Biogenesis Bago Animal Antibacterial Peptide Product Offerings
    Table 86. Biogenesis Bago Recent Development
    Table 87. Animal Medics Company Information
    Table 88. Animal Medics Introduction and Business Overview
    Table 89. Animal Medics Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 90. Animal Medics Animal Antibacterial Peptide Product Offerings
    Table 91. Animal Medics Recent Development
    Table 92. Boehringer Ingelheim Vetmedica Company Information
    Table 93. Boehringer Ingelheim Vetmedica Introduction and Business Overview
    Table 94. Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 95. Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Product Offerings
    Table 96. Boehringer Ingelheim Vetmedica Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Animal Antibacterial Peptide Downstream Customers
    Table 100. Animal Antibacterial Peptide Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Animal Antibacterial Peptide Product Picture
    Figure 2. Global Animal Antibacterial Peptide Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Animal Antibacterial Peptide Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Animal Antibacterial Peptide Sales Volume (2019-2030) & (K MT)
    Figure 5. Global Animal Antibacterial Peptide Sales Price (2019-2030) & (USD/MT)
    Figure 6. Animal Antibacterial Peptide Report Years Considered
    Figure 7. Global Animal Antibacterial Peptide Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Animal Antibacterial Peptide Players Sales Volume Ranking (2023) & (K MT)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Animal Antibacterial Peptide Revenue in 2023
    Figure 10. Animal Antibacterial Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Anionic Peptides Picture
    Figure 12. Cationic Peptide Picture
    Figure 13. Global Animal Antibacterial Peptide Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Animal Antibacterial Peptide Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Animal Antibacterial Peptide Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
    Figure 16. Global Animal Antibacterial Peptide Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Animal Antibacterial Peptide Price by Type (2019-2030) & (USD/MT)
    Figure 18. Product Picture of Poultry
    Figure 19. Product Picture of Livestock
    Figure 20. Global Animal Antibacterial Peptide Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Animal Antibacterial Peptide Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Animal Antibacterial Peptide Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
    Figure 23. Global Animal Antibacterial Peptide Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Animal Antibacterial Peptide Price by Application (2019-2030) & (USD/MT)
    Figure 25. North America Animal Antibacterial Peptide Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Animal Antibacterial Peptide Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Animal Antibacterial Peptide Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Animal Antibacterial Peptide Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Animal Antibacterial Peptide Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Animal Antibacterial Peptide Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Animal Antibacterial Peptide Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Animal Antibacterial Peptide Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Animal Antibacterial Peptide Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Animal Antibacterial Peptide Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Animal Antibacterial Peptide Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Animal Antibacterial Peptide Sales Volume (%), (2019-2030)
    Figure 37. United States Animal Antibacterial Peptide Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Animal Antibacterial Peptide Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Animal Antibacterial Peptide Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Animal Antibacterial Peptide Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Animal Antibacterial Peptide Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Animal Antibacterial Peptide Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Animal Antibacterial Peptide Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Animal Antibacterial Peptide Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Animal Antibacterial Peptide Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Animal Antibacterial Peptide Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Animal Antibacterial Peptide Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Animal Antibacterial Peptide Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Animal Antibacterial Peptide Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Animal Antibacterial Peptide Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Animal Antibacterial Peptide Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Animal Antibacterial Peptide Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Animal Antibacterial Peptide Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Animal Antibacterial Peptide Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Animal Antibacterial Peptide Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Animal Antibacterial Peptide Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Animal Antibacterial Peptide Sales Value by Application (%), 2023 VS 2030
    Figure 58. Animal Antibacterial Peptide Industrial Chain
    Figure 59. Animal Antibacterial Peptide Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS